Forge Therapeutics acquired spinoff Blacksmith Medicines while solar film producer Sinopont raised $145m in series D funding.

inflammatory disease

M&A

Antibiotic drug provider Forge Therapeutics has agreed to pay an undisclosed amount to acquire Blacksmith Medicines, a US-based inflammatory diseases therapy developer spun off by the corporate in early 2021. It had received an undisclosed amount of seed financing from investors including pharmaceutical companies Eli Lilly and Evotec as well as Alexandria Venture Investments, a subsidiary of life sciences real estate investment trust Alexandria Real Estate Equities.

Meta, the owner of social media platforms Facebook and Instagram, has bought Luxexcel, a Netherlands-based smart eyewear provider that counts process control equipment manufacturer KLA Tencor, for an undisclosed amount, De Tijd has reported. The corporate invested through a series C round which stood at $16.4m as of 2017, lifting Luxexcel’s total funding to over $24m.

Fund

KuCoin Labs, the Seychelles-based incubation and research subsidiary of cryptocurrency exchange KuCoin, has formed an incubation initiative called KuCoin Labs Incubation Program to build blockchain startups. Smartphone producer Vertu has backed the scheme, as have MoonRock Capital, CDH Investment, IOBC Capital, Matrix Partners and unnamed other investors.

Funding

Company Company description Sector Country Round Round size($m) Deal date Investors
Zhejiang Sinopont Technology Solar photovolatic film manufacturer Energy and Natural Resources China D 145 02/01/2023 State Power Investment Corporation (SPIC Industrial Fund Management); GGV Capital, Citic Securities (Citic Goldstone Fund Management), Source Code Capital, China International Capital Corporation (CICC Capital)
Hyseim Semiconductor technology developer IT China Pre-A 14.5 30/12/2022 XinComm; Sunic Capital (co-lead), C&D Fund (co-lead), Weed Venture Capital, Clivia Capital
Legit Group Cloud kitchen operator Consumer Indonesia A 9.4 02/01/2023 Telkom Indonesia (MDI Ventures), Sinar Mas (SMDV); East Ventures
Elchemy Online chemical marketplace Industrial India Pre-seed 2 01/01/2023 Info Edge (Info Edge Ventures) (lead); unnamed angel investors
TSG Therapeutics Infectious disease therapy developer Healthcare Singapore N/A 1.6 03/01/2023 Daehan New Pharm
FinAccel Mobile financial services provider Financial Singapore N/A 1.3 03/01/2023 Westpac (Reinventure)
Clean Max Thanos Renewable power provider Energy and Natural Resources India N/A <1 (460,000) 02/01/2023 Welspun
Decans Orthopaedic surgery technology developer Healthcare China B+ N/A 30/12/2022 Zhejiang Jiaxin Silk Corp; ZSCO (Guogai Capital) (lead), Suzhou Huanxiu Lake Venture Capital Center, Everchanting Fund, Lishui Fuchu Fund
Hongxin Biotech Gynaecological mRNA drug developer Healthcare China Angel+ N/A 30/12/2023 Hinova Pharmaceuticals, Dongbao Enterprise Group; Hongtao Fund Management, Nanling Fund, Shenzhen Credit Guarantee Group, Goldport Capital
Fande Technology Enterprise automation system provider Industrial China Angel N/A 30/12/2022 Infaith Group; Sinovation Ventures (lead), Tsinghua University (TusStar)
Edison Fu

Edison Fu is head of Asia development at Global Corporate Venturing.